How forward-thinking families are using second residencies to access longevity clinics, preventative diagnostics, and specialized treatments unavailable at home.
The longevity industry has matured rapidly over the past five years, with leading clinics now operating across Switzerland, Portugal, Greece, and parts of Latin America. For families serious about extending healthspan, geographic flexibility is no longer a luxury — it is a prerequisite.
A second residency is the legal foundation that makes long-term longevity planning possible. Tourist visas cap stays at 90 days in most jurisdictions, which is rarely enough for meaningful diagnostics, follow-up protocols, and continuity of care.
What to Look For in a Longevity-Friendly Jurisdiction
Three factors matter most: the quality of local diagnostic infrastructure, the regulatory environment for emerging therapies, and the ease of bringing in international specialists. Countries that score well across all three — including Portugal and Greece — have become natural hubs for the longevity-minded investor.
Coordinating Residency and Care
The most effective approach is to align the residency application timeline with an initial diagnostic intake at a partnered clinic. This allows families to use their first qualifying stay productively, establishing a baseline that subsequent visits can build on.
The bottom line: longevity planning and residency planning are increasingly the same conversation.